| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20014078 | HPV | ENSG00000171862.16 | protein_coding | PTEN | No | Yes | 5728 | F6KD01 P60484 |
| TVIS44050827 | HTLV-1 | ENSG00000171862.16 | protein_coding | PTEN | No | Yes | 5728 | F6KD01 P60484 |
| TVIS44049361 | HTLV-1 | ENSG00000171862.16 | protein_coding | PTEN | No | Yes | 5728 | F6KD01 P60484 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PTEN |
|---|---|
| DrugBank ID | DB04327 |
| Drug Name | Phosphatidylethanolamine |
| Target ID | BE0005530 |
| UniProt ID | P60484 |
| Regulation Type | substrate |
| PubMed IDs | 15313215 |
| Citations | Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G: Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys. 2004 Sep 15;429(2):123-33. |
| Groups | Experimental |
| Direct Classification | Phosphatidylethanolamines |
| SMILES | CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO[P@](O)(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC |
| Pathways | |
| PharmGKB | |
| ChEMBL |
